Books on the topic 'Pharmaceutical fraud'

Prescription drug abuse, doctor shopping, and the role of Medicaid. Hauppauge] New York: Novinka, Nova Science Publishers, Inc., 2012.

Pharmaceutical anti-counterfeiting: Combating the real danger from fake drugs. Hoboken, N.J: Wiley, 2011.

Control, United States Congress House Select Committee on Narcotics Abuse and. Pill mills, Medicaid fraud, and the diversion of pharmaceuticals: Hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, One Hundred Second Congress, second session, July 29, 1992. Washington: U.S. G.P.O., 1992.

Medicare Part D: Instances of questionable access to prescription drugs : report to congressional requesters. Washington, D.C.]: U.S. Govt. Accountability Office, 2011.

Curbing prescription drug abuse in Medicare: Hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Thirteenth Congress, first session, June 24, 2013. Washington: U.S. Government Printing Office, 2014.

Risk-based monitoring and fraud detection in clinical trials using JMP and SAS / Richard C. Zink. Cary, N.C: SAS Institute, 2014.

California. Bureau of State Audits. Department of Health Services: Use of its port of entry fraud detection programs is no longer justified. Sacramento, Calif. (555 Capitol Mall, Suite 300, Sacramento 95814): Bureau of State Audits, 1999.

Eban, Katherine. Dangerous doses: How counterfeiters are contaminating America's drug supply. Orlando: Harcourt, 2005.

United States. Government Accountability Office, ed. Medicare Part D: CMS conducted fraud and abuse compliance plan audits, but all audit findings are not yet available. Washington, DC: U.S. Govt. Accountability Office, 2011.

Costs of prescription drug abuse in the Medicare Part D program: Hearing before the Federal Financial Management, Government Information, Federal Services, and International Security Subcommittee of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Twelfth Congress, first session, October 4, 2011. Washington: U.S. G.P.O., 2012.

1957-, Ding Hong, ed. Zhen zhen jia jia: Yi liao pian shu yu mei rong miu wu da pu guang. Xinjiapo: Ba fang wen hua chuan zuo shi, 2006.

Phake: The deadly world of falsified and substandard medicines. Washington, D.C: AEI Press, 2012.

Making a killing: The deadly implications of the counterfeit drug trade. Washington, D.C: AEI Press, 2008.

The war against counterfeit medicine: My story. Ibadan: Safari Books Ltd, 2011.

Real or not: Health scams and beauty fallacies exposed. Hackensack, NJ: World Scientific, 2005.

Koyalta, Donato. La distribution des médicaments au Tchad: Fraude ou souci de qualité! N'Djaména: CEFOD, 1998.

Koyalta, Donato. La distribution des médicaments au Tchad: Fraude ou souci de qualité! N'Djaména: CEFOD, 1998.

Allegations of waste, fraud, and abuse in pharmaceutical pricing: Financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007. Washington: U.S. G.P.O., 2007.

Audits, California Bureau of State. Department of Health Services: Has made little progress in protecting California's children from lead poisoning. Sacramento, Calif. (555 Capitol Mall, Suite 300, Sacramento, 95814): Bureau of State Audits, 1988.

Audits, California Bureau of State. Department of Health Services: It needs to better control the pricing of durable medical equipment and medical supplies and more carefully consider its plans to reduce expenditures on these items. Sacramento, Calif. (555 Capitol Mall, Suite 300, Sacramento, 95814): Bureau of State Audits, 2002.

California. Bureau of State Audits. Department of Health Services: A conflict of interest did not cause the Fresno district's inadequate oversight of skilled nursing facilities. Sacramento, Calif. (555 Capitol Mall, Suite 300, Sacramento, 95814): The Bureau, 2000.

California. Bureau of State Audits. Department of Health Services: Despite shortcomings in the Department's monitoring efforts, limited data suggest its two-plan model does not adversely affect quality of and access to health care. Sacramento, Calif. (555 Capitol Mall, Suite 300, Sacramento, 95814): Bureau of State Audits, 1999.

California. Bureau of State Audits. Department of Health Services: The forensic alcohol program needs to reevaluate its regulatory efforts. Sacramento, Calif: The Bureau, 1999.

California. Bureau of State Audits. Department of Health Services: Some of its policies and practices result in higher state costs for the Medical Therapy Program. Sacramento, CA: California State Auditor, Bureau of State Audits, 2004.

California. Bureau of State Audits. Department of Health Services: Its drug management techniques are similar to those of health maintenance organizations. Sacramento, Calif: Bureau of State Audits, 1997.

California. Bureau of State Audits. Department of Health Services: Additional improvements are needed to ensure children are adequately protected from lead poisoning. Sacramento, Calif. (555 Capitol Mall, Suite 300, Sacramento, 95814): Bureau of State Audits, 2001.

California. Bureau of State Audits. Department of Health Services: Its efforts to further reduce prescription drug costs have been hindered by its inability to hire more pharmacists and its lack of aggressiveness in pursuing available cost-saving measures. Sacramento: California State Auditor, Bureau of State Audits, 2003.

Experiment Eleven: Dark secrets behind the discovery of a wonder drug. New York, N.Y: Walker & Co., 2012.

Davison, Mark. Pharmaceutical Anti-Counterfeiting. Wiley & Sons, Incorporated, John, 2011.

Ray, Sumantra (Shumone), Sue Fitzpatrick, Rajna Golubic, Susan Fisher, and Sarah Gibbings, eds. Fraud and misconduct. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199608478.003.0025.

Davison, Mark. Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs. Wiley & Sons, Incorporated, John, 2011.

Pill mills, Medicaid fraud, and the diversion of pharmaceuticals: Hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, One Hundred Second Congress, second session, July 29, 1992. Washington: U.S. G.P.O., 1993.

Hall, Alexandra, and Georgios A. Antonopoulos. Fake Meds Online: The Internet and the Transnational Market in Illicit Pharmaceuticals. Palgrave Macmillan, 2017.

Hall, Alexandra, and Georgios A. Antonopoulos. Fake Meds Online: The Internet and the Transnational Market in Illicit Pharmaceuticals. Palgrave Macmillan, 2016.

Hall, Alexandra, and Georgios A. Antonopoulos. Fake Meds Online: The Internet and the Transnational Market in Illicit Pharmaceuticals. Palgrave Macmillan, 2016.

Dangerous Doses: A True Story of Cops, Counterfeiters, and the Contamination of America's Drug Supply. Harvest Books, 2006.

Eban, Katherine. Dangerous Doses: How Counterfeiters Are Contaminating America's Drug Supply. Harcourt, 2005.

Eban, Katherine. Dangerous Doses: A True Story of Cops, Counterfeiters, and the Contamination of America's Drug Supply. Houghton Mifflin Harcourt Trade & Reference Publishers, 2006.

Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Lawrence O. Gostin, Institute of Medicine, Board on Global Health, and Gillian J. Buckley. Countering the Problem of Falsified and Substandard Drugs. National Academies Press, 2013.

Gostin, Lawrence O., Institute of Medicine Staff, Board on Global Health Staff, Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products Committee, and Gillian J. Buckley. Countering the Problem of Falsified and Substandard Drugs. National Academies Press, 2013.

Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Lawrence O. Gostin, Institute of Medicine, Board on Global Health, and Gillian J. Buckley. Countering the Problem of Falsified and Substandard Drugs. National Academies Press, 2013.

Phake: The Deadly World of Falsified and Substandard Medicines. American Enterprise Institute for Public Policy Research, 2012.

Making a Killing: The Deadly Implications of the Counterfeit Drug Trade. American Enterprise Institute for Public Policy Research, 2008.

Making a Killing: The Deadly Implications of the Counterfeit Drug Trade. American Enterprise Institute for Public Policy Research, 2008.

Bottle of Lies: The Inside Story of the Generic Drug Boom. Ecco, 2019.

An America I Never Knew A True Story. Channel Photographics, 2010.

Experiment Eleven: Deceit and Betrayal in the Discovery of the Cure for Tuberculosis. Bloomsbury Publishing Plc, 2013.

US GOVERNMENT. Pill mills, Medicaid fraud, and the diversion of pharmaceuticals: Hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, ... Congress, second session, July 29, 1992. For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.

Experiment Eleven: Dark Secrets Behind the Discovery of a Wonder Drug. Bloomsbury USA, 2013.

Pringle, Peter. Experiment Eleven: Deceit and Betrayal in the Discovery of the Cure for Tuberculosis. Bloomsbury Publishing Plc, 2012.